Close Menu

Genetics & Genomics Business, Policy & Funding

Breaking news on Genetics & Genomics business, policy & funding.

The National Institutes of Health also said that it has added four additional healthcare provider organizations to help advance the initiative.

The investment bank projects medium-term revenue growth in the low teens, thanks to new test launches and expanded payor contracts for the company.

Wren Laboratories and P23 Labs received revised EUAs that allow their previously authorized tests to now be used with new specimen types.

A bi-weekly listing of recent local coverage determinations from Medicare Administrative Contractors.

The UK and the European Union have come to a sticking point in the negotiation of how the UK might remain involved in the Horizon Europe research program, the Guardian reports.

The New York Times reports that experts pushed during a meeting of an FDA advisory board for the agency to require more safety data from SARS-CoV-2 vaccine trials.

The Washington Post reports Moderna expects that it will have enough data on its candidate SARS-CoV-2 vaccine to submit to regulatory authorities by mid-November.

In Science this week: ANXA11 variants affect calcium homeostasis and stress granule disassembly in ALS, and more.